A recent study published in *Frontiers in Pediatrics* investigates the relationship between baseline gut microbiome features and the fecal calprotectin response to exclusive enteral nutrition (EEN) in children with Crohn's disease. EEN is a common induction therapy, but patient responses can vary significantly.
Read More
The researchers utilized two public pediatric cohorts, PRJEB14084 and PRJEB33603. They analyzed paired microbiome profiles from patients before and after treatment, focusing on correlations with fecal biochemical data. The study found that while several genera showed consistent changes during EEN, the prediction model had only modest discriminatory power in identifying responders based on microbiome composition. The area under the receiver operating characteristic curve (AUC) for the baseline model was calculated at 0.655, with a 95% confidence interval ranging from 0.450 to 0.850.
The analysis showed reductions in total amino acids and tryptophan, alongside increases in the proportion of secondary bile acids and the hydrophobicity index by the end of treatment. In follow-up assessments, responders exhibited a decrease in discriminant metabolites, whereas non-responders retained a broader array of significant biochemical markers.
This observational study provides insights into how EEN influences the gut microbiome and its potential association with biochemical responses in pediatric patients. However, the findings emphasize the need for cautious interpretation, as the estimates remain imprecise and primarily exploratory. The authors suggest prospective studies for validating these associations and improving clinical utility in treatment strategies for pediatric Crohn's disease.